F. Vranceanu

Striated organelle, a cytoskeletal structure positioned to modulate hair-cell transduction

Mark Ellisman, G. Perkins, A. Lysakowski, 2012, Proceedings of the National Academy of Sciences.

Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials

Edward S. Kim, H. Groen, E. Smit, 2022, JTO clinical and research reports.

Brigatinib versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial.

Jie Yang, S. Gettinger, M. Ahn, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells

Bahram Valamehr, A. Medcalf, F. Vranceanu, 2014, Stem cell reports.

Optimized Surface Markers for the Prospective Isolation of High-Quality hiPSCs using Flow Cytometry Selection

Bahram Valamehr, F. Vranceanu, M. Robinson, 2013, Scientific Reports.

Brigatinib versus Crizotinib in Anaplastic Lymphoma Kinase (ALK) Inhibitor-Naive Advanced ALK-Positive Non-Small Cell Lung Cancer: Final Results of the Phase 3 ALTA-1L Trial.

S. Gettinger, M. Ahn, E. Felip, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.